leaves varies considerably with season, reaching a maximum content as the plant approaches full flowering. 5a Plant material is normally processed with MeOH or EtOH and narciclasine is separated through solvent partitioning and chromatographic purification. In our hands, narciclasine has been isolated over several years following literature procedures in quantities approaching 50 mg/kg wet bulbs. We have now developed an optimized, alternative isolation protocol in which extraction of the plant material into MeOH (48 h), dilution with 250 mL of H2O, and concentration yields an aqueous extract from which the less polar materials are removed by extraction into DCM. The optimized process involves extraction of the remaining aqueous residue with a mixture of EtOAc and MeOH (9:1). This process allows clean extraction of narciclasine and a trace contaminant into the EtOAc phase from the polar aqueous phase. A single chromatographic purification then allows isolation of narciclasine in pure form.
The initial DCM extraction process completely removes other compounds such as galanthamine (6) and a contaminant that has a similar Rf to narciclasine. This compound was identified as the crinane alkaloid, haemanthamine (5). The 1 H and 13 C NMR data of haemanthamine proved identical to the reported data. 12, 13 However, analysis of the 1 H-1 H and 1 H- these carbon and proton signals should therefore be reversed. 12, 13 Analysis of the EtOAc content from Narcissus by TLC showed essentially single-spot separation; however, the 1 H NMR data show the presence of narciclasine and a trace of an unidentified contaminant. The NMR data of narciclasine and the trace contaminant did not permit identification by comparison with known co-metabolites. 5a The presence of minor peaks for a methylenedioxy -CH2-and an olefinic proton ( 1 H NMR: 6.06-6.12 ppm) led to a hypothesis that this material may be a minor epimer of narciclasine. Purification of the EtOAc soluble portion from Narcissus by chromatography on silica yields off-white narciclasine in high yield (120 mg/kg). The disappearance of the minor metabolite upon a single silica-gel column led to the assumption that the compound may be the C-2-allylic alcohol epimer. Thus, 2-epi-narciclasine became a target for semisynthesis from narciclasine and also for a de novo total synthesis (vide infra). This work and a direct comparison provided proof that the minor isomer from Narcissus is not the C-2-epimer and this unstable minor compound remains unidentified. Access to authentic 2-epi-narciclasine obtained by semi-synthesis (vide infra) and also by de novo total synthesis (Scheme 4) and comparison with extracts of Narcissus by LC-MS confirmed the absence of this metabolite in Narcissus. However, surprisingly, an identical analysis of an extract of Galanthus by LC-MS allowed confirmation of the presence of the 2-epimer by comparison of MS and LC-MS data.
Conversion of Narciclasine to 2-epi-Narciclasine.
A. Mitsunobu Inversion. In an attempt to convert narciclasine to its C-2 epimer Mitsunobu reaction conditions with tributylphosphine and benzoic acid were first applied to the 3,4-acetonide protected allylic alcohol 8. Although starting material was consumed, none of the target product was isolated. Instead, elimination took place, most likely from the C-2-alkoxyphosphonium intermediate, and yielded the mixture of dienamine 9 and benzoic acid (1:1) in 30% yield (Scheme 1).
Scheme 1.
Attempted Mitsunobu Reaction of Narciclasine-3,4-acetonide.
The Mitsunobu reaction was next attempted on compound 8 under alternative conditions using triphenylphosphine and DIAD (Scheme 2). These conditions resulted in the formation of the target product 10 (16%) and the product of allylic alcohol oxidation, followed by olefin migration to give the stable conjugated enamine 11 (84%). This rearrangement of the double bond into the lactam moiety has previously been reported. 14 In the present case, the reaction produced an inseparable mixture of the products 10 and 11. Most interestingly, treatment of the mixture with TFA, in an attempt to remove the acetonide, yielded a major product in 35% isolated yield from acetonide 8.
This product proved to be identical with the minor Amaryllidaceae constituent narciprimine (7), a compound that exhibits acetylcholinesterase inhibitory activity.
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Scheme 2. Second Attempt at a Mitsunobu Inversion at C-2 in Narciclasine-3,4-acetonide 8.
B. Oxidation/Reduction Sequence. Because of the failure of the direct C-2-inversion reactions,
an alternative attempt at the conversion of narciclasine to its C-2 epimer was investigated involving the oxidation of the C-2 allylic alcohol group and stereoselective reduction. This sequence also proved problematic: Oxidation of compound 8 was unsuccessful under Swern as well as Dess-Martin conditions. Enone 12 was prepared by oxidation of narciclasine with MnO2, but its isolation was arduous because of its instability. As noted in the original publication by Krohn, enone 12 readily rearranges to its deconjugated isomer 11 (Scheme 3). 14 Attempts to perform a one pot oxidation/reduction without isolation of enone 12 proved irreproducible and only traces of allylic alcohol 13 were observed in reaction mixtures.
Scheme 3.
Oxidation/Reduction of Protected Narciclasine (free phenol at C-7).
We suspected that the free phenolic moiety might be contributing to the problem encountered in oxidations of the C-2 allylic alcohol moiety and to the instability of enone 12. Thus, narciclasine was treated with diazomethane to produce the methyl ether 14, whose protection as an acetonide yielded compound 15, Scheme 4. The allylic alcohol was oxidized under Dess-Martin conditions to . 16 The allylic alcohol 23 was deprotected with 2 M HCl and the resulting triol 24 was reprotected as triacetate 25. Formation of ring B of the narciclasine backbone was achieved employing the Banwell modified Bishler-Napieralski reaction and yielded phenantridone 26. 17 Deprotection of 26 can be accomplished in two ways: a) O-demethylation (yielding compound 27), followed by hydrolysis of acetoxy groups or b) hydrolysis of acetoxy groups (yielding compound 18), followed by O-demethylation. The initial pathway was combined in one pot 8 and furnished 2-epi-narciclasine (19) in 50% yield over the two steps. As stated above, 2-epinarciclasine was not detected in the crude extract from Narcissus ( Figure 2B and 2D).
The literature contains a few misleading references to this epimer, including the structure as represented by (19) . 18 This arose from initial misassignment of the structure of narciclasine (1), which was corrected by Krohn and Mondon in 1972. 19 They synthesized oxygenated derivatives and compared their 1 H NMR data with those of isomerized narciclasine derivative. In this manner the correct C-2 configuration was reassigned for the natural product, as shown in Figure 1 . in the EtOAc extract of N. pseudonarcissus was hypothesized to be 2-epi-narciclasine leading to both the semi-and total syntheses of this 2-epimer. This compound proved not to be identical to a minor metabolite, whose constitution is as-yet unidentified. Nonetheless, through an interesting twist of fate, 2-epi-narciclasine was identified as a trace metabolite (< 1.0 ppm) in an extract of Galanthus sp. and is here reported as a natural product for the first time. Attempted Mitsunobu inversions of the allylic alcohol functionality in narciclasine as an entry to the C-2 epimer were complicated by side reactions, however this work resulted in a serendipitous synthetic entry to the natural product narciprimine.
Analysis of the crude extracts of N. pseudonarcissus and Galanthus sp. using LC-MS and synthesized standards confirmed the presence of narciclasine, haemanthamine, and narciprimine in both extracts, and the trace occurrence of 2-epi-narciclasine in only the Galanthus sample. Given the low natural abundance of 2-epi-narciclasine the optical rotation data or a detailed analysis on a chiral support and comparison with the racemate could not be obtained. The overall absolute configuration is assumed to be in accord with related lycoranes such as narciclasine and pancratistatin. Of special note is the rare fact that this total synthesis of 2-epi-narciclasine preceded its identification as a natural product EXPERIMENTAL SECTION General Experimental Procedures: All solvents were dried and distilled before usage.
Reactions were done in inert atmosphere (Ar or N2). All reagents were obtained from commercial sources. Before using, all glassware was oven or flame dried. NMR analysis was carried out on 400, 600, and Bruker AV-III 700 mHz spectrometers running Topspin 2.1 and 3.5 software. Probes were equipped with gradients and VT (variable temperature) accessories. Chemical shifts are given in δ, and coupling constants J are given in Hz. Melting points were determined using a capillary melting point apparatus. HRMS data were recorded using an LTQ Orbitrap XL or double focusing sector (DFS) mass spectroscopy, and the mass ion was determined by electrospray ionization, fast atom bombardment, or electron ionization. Infrared spectra were recorded on an FT-IR spectrophotometer give approximately 250 mL of an aqueous residue which was further diluted with water (250 mL).
The aqueous phase was extracted with DCM (3×250 mL). The combined DCM phases were concentrated in vacuo giving a residue (12.8g) which was purified by column chromatography 
(3aS,3bR,12S,12aR)-6,12-Dihydroxy-2,2-dimethyl-3b,4,12,12a-tetrahydrobis[1,3]dioxolo[4,5-c:4',5'-j]phenanthridin-5(3aH)-one (8):
Protocol A. Narciclasine (1) (10 mg, 0.032 mmol) was suspended in DCM (3 mL), and 2,2-DMP (0.3 mL) added followed by addition of p-TSA (cat.). The mixture was stirred at room temperature for 2 h. The reaction mixture was adsorbed on deactivated silica and purified by flash column chromatography (EtOAc:hexanes 1:2 to 1:1). The product was isolated as a colorless oily solid, 8 mg, 71%. Narciprimine (4, 3] dioxolo [4,5-j] phenanthridin-6(5H)-one, (7) . Narciprimine (7) 
(2R,3R,4S,4aR)-2,3,4-Trihydroxy-7-methoxy-3,4,4a,5-tetrahydro-3,4-[a][2,2-dimethyl-1,3-
dioxolanyl]- [1, 3] dioxolo [4,5-j] 
2-epi-7-Methoxynaciclasine [(2R,3R,4S,4aR)-2,3,4-Trihydroxy-7-methoxy-3,4,4a,5-
tetrahydro- [1, 3] dioxolo [4,5-j] and THF (1:2, 3 mL) and 6 M HCl (0.5 mL) was added dropwise at room temperature. The reaction mixture was stirred for 15 min, quenched with a saturated solution of NaHCO3 (5 mL), and extracted with DCM (3×10 mL). The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure. The triol was purified by column chromatography 
